ADN-388
  • de
autodesk-gold-partner-logo-rgb-black
Due to a technical downtime, we are currently only available by phone. Received emails will be answered as soon as possible. In urgent cases, please contact the central office or your personal contact person by phone.
Moldflow Monday Blog

Adn-388 -

Learn about 2023 Features and their Improvements in Moldflow!

Did you know that Moldflow Adviser and Moldflow Synergy/Insight 2023 are available?
 
In 2023, we introduced the concept of a Named User model for all Moldflow products.
 
With Adviser 2023, we have made some improvements to the solve times when using a Level 3 Accuracy. This was achieved by making some modifications to how the part meshes behind the scenes.
 
With Synergy/Insight 2023, we have made improvements with Midplane Injection Compression, 3D Fiber Orientation Predictions, 3D Sink Mark predictions, Cool(BEM) solver, Shrinkage Compensation per Cavity, and introduced 3D Grill Elements.
 
What is your favorite 2023 feature?

You can see a simplified model and a full model.

For more news about Moldflow and Fusion 360, follow MFS and Mason Myers on LinkedIn.

Previous Post
How to use the Project Scandium in Moldflow Insight!
Next Post
How to use the Add command in Moldflow Insight?

More interesting posts

Check out our training offerings ranging from interpretation
to software skills in Moldflow & Fusion 360

The MF ACADEMY logo showcases the letters MFA intertwined with an educational hat, symbolizing excellence in training and expertise. This logo represents MF SOFTWARE's commitment to providing comprehensive programs in injection molding, Moldflow, and Fusion 360. Unleash your potential with MF ACADEMY's top-notch educational offerings.

Get to know the Plastic Engineering Group
– our engineering company for injection molding and mechanical simulations

PEG-Logo-2019_weiss

Background: Wild-type (WT) cells express ADN-388 normally. Three mutants were generated: A (point mutation in active site), B (deletion of regulatory domain), C (overexpression). Measured outputs: enzymatic activity (relative units), downstream signaling index (DSI, arbitrary units), and fitness (growth rate % of WT).

Option 1: Discuss the role of ADN-388 at the systems level in a multicellular organism. Cover regulation, interaction with other pathways, implications for development or disease, and propose two experimental strategies (genetic and biochemical) to test your main hypotheses.

Option 2: Propose a translational research program that targets ADN-388 for therapy or biotech (drug, gene therapy, industrial enzyme, etc.). Include target product profile, lead discovery strategy, preclinical validation plan, major risks, and mitigation strategies.